Clinical Trial

AI and VR Devices for Eating Behavior Rehabilitation

Study acronym: ARCADIA-VR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Eating disorders (ED) affect the relationship with food and body image. Virtual reality (VR), combined with artificial intelligence (AI), offers new clinical solutions, overcoming traditional cognitive behavioral therapy (CBT). The ARCADIA VR project aims to develop devices to treat ED through personalized VR systems (e.g. Enhanced Body-Swap for anorexia, Emotional Rescripting for bulimia) and AI predictive algorithms to monitor severity, risk and efficacy of treatments. These approaches promise better and faster results, improving diagnosis and treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-24.
Status change: Not Yet Recruiting → Recruiting 2025-04-29
Trial Details
NCT Number NCT06799962
Lead Sponsor Istituto per la Ricerca e l'Innovazione Biomedica
Collaborators: Madre Teresa s.r.l, Medilink s.r.l., SB SETEC S.p.A, Catholic University of the Sacred Heart
Conditions Eating Disorders, Anorexia Nervosa, Bulimia Nervosa
Enrollment 80 participants
Start Date 2025-01-30
Primary Completion 2025-07-30 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-30